Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Clinical trial NCT00075959 · COMPLETED

Trial details

NCT number: NCT00075959
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Intracerebral Hemorrhage

Start date: 2004-08-01
Primary completion: 2006-01-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.